Effects of vestibular rehabilitation and pharmacological therapy in patients with vestibular migraine

Basit Öğe Kaydı
dc.contributor.authorAydin, Isa
dc.contributor.authorGokcay, Figen
dc.contributor.authorKarapolat, Hale
dc.contributor.authorEraslan, Sevinc
dc.contributor.authorBilgen, Cem
dc.contributor.authorKirazli, Tayfun
dc.contributor.authorCelebisoy, Nese
dc.date.accessioned2020-12-01T11:59:04Z
dc.date.available2020-12-01T11:59:04Z
dc.date.issued2020
dc.departmentEge Üniversitesien_US
dc.description.abstractObjectives: the objectives of this study were to compare the results of pharmacologic management options and vestibular rehabilitation (VR) programs in the context of dizziness, balance problems, and headache in patients with vestibular migraine. Materials and Methods: Sixty patients with migraine with vestibular symptoms were evaluated in three groups in the neurology, physical medicine, and rehabilitation and otorhinolaryngology clinics of a medical school hospital. the groups were defined as routine pharmacologic therapy (PT), VR, or both. Patients were evaluated with static posturography, the Dizziness Handicap Inventory (DHI), and the Activities-Specific Balance Confidence (ABC) Scale as primary outcome measures and symptom frequency and severity (headaches and vertigo attacks) as secondary outcome measures. In-group and between-group comparisons were made using relevant statistical methods. Results: DHI scores were significantly reduced (P < 0.001) in all treatment groups. ABC scores increased significantly (P < 0.001) in patients taking PT and those on VR + PT. Posturographic examinations revealed that sway velocity values recorded on foam with eyes closed, which targets vestibular assessment, were significantly reduced (P < 0.001) in groups taking VR either alone or with PT. VR benefited patients with migraine in terms of headaches, vertigo attack frequency, intensity, and duration. Conclusion: Patients with predominant vestibular disorders can benefit from VR alone, and patients with combined symptoms (headache and vertigo) can benefit from pharmacologic and rehabilitation therapies.en_US
dc.identifier.doi10.4103/NSN.NSN_41_20
dc.identifier.endpage117en_US
dc.identifier.issn2636-865X
dc.identifier.issn2636-865Xen_US
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85092105950en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage110en_US
dc.identifier.urihttps://doi.org/10.4103/NSN.NSN_41_20
dc.identifier.urihttps://hdl.handle.net/11454/62178
dc.identifier.volume37en_US
dc.identifier.wosWOS:000574527400002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofNeurological Sciences and Neurophysiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBalance disordersen_US
dc.subjectexerciseen_US
dc.subjectheadacheen_US
dc.subjectpharmacologic therapyen_US
dc.subjectrehabilitationen_US
dc.subjectvestibular migraineen_US
dc.titleEffects of vestibular rehabilitation and pharmacological therapy in patients with vestibular migraineen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu